Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Journal of the National Cancer Institute|July 17, 1998
Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumorsW H Gotlieb, E Friedman, R B Bar-Sade, et al.
Gynecologic Oncology|September 28, 2000
Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations statusA Fishman, E Dekel, A Chetrit, et al.
Paediatric and Perinatal Epidemiology|August 10, 1999
SEARCH international case-control study of childhood brain tumours: role of index pregnancy and birth, and mother's reproductive historyM McCredie, J Little, S Cotton, et al.
The New England Journal of Medicine|July 28, 2001
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutationB Modan, P Hartge, G Hirsh-Yechezkel, et al.
Environmental Health Perspectives|July 1, 1998
Results from an international case-control study of childhood brain tumors: the role of prenatal vitamin supplementationS Preston-Martin, J M Pogoda, B A Mueller, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|December 5, 1998
Prenatal vitamin supplementation and pediatric brain tumors: huge international variation in use and possible reduction in riskS Preston-Martin, J M Pogoda, B A Mueller, et al.
JAMA|December 11, 1996
High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian CancerB Modan, E Gak, R B Sade-Bruchim, et al.
Human Molecular Genetics|May 23, 1998
The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to AshkenazimR B Bar-Sade, A Kruglikova, B Modan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Effect of BRCA mutations on the length of survival in epithelial ovarian tumorsY Ben David, A Chetrit, G Hirsh-Yechezkel, et al.
British Journal of Urology|December 11, 1997
Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic HyperplasiaJ L Donovan, H E Kay, T J Peters, et al.
Pageof 27